Lifeway Foods, Inc. — Q1 2022 Form 10-Q
Business context and period: The filing reports Lifeway Foods, Inc. and subsidiaries for the three months ended March 31, 2022, with comparison to Q1 2021. Lifeway primarily sells cultured dairy products, including drinkable kefir, and reports one operating segment. Financial amounts below are in millions of dollars unless stated otherwise.
Key financial results
| Metric | Q1 2022 | Q1 2021 |
|---|---|---|
| Net sales | $34.1 | $29.4 |
| Gross profit / margin | $5.6 / 16.4% | $8.0 / 27.4% |
| Operating income (loss) | ($1.0) | $1.9 |
| Net income (loss) | ($0.9) | $1.3 |
| Basic and diluted EPS | ($0.06) | $0.08 |
| Cash from operations | ($0.6) | $1.2 |
| Capital expenditures | $0.3 | $0.5 |
Sales increased 16.1%, attributed mainly to higher branded drinkable kefir volume and price increases, with a smaller contribution from the 2021 GlenOaks Farms acquisition. Gross margin fell 11.0 percentage points; management cited higher milk prices and, to a lesser extent, freight and other input costs. General and administrative expense rose $0.4 million, primarily due to legal and professional fees, including costs related to the 2020 Form 10-K restatement. Selling expense was broadly unchanged. The quarter included $0.1 million of intangible amortization; a brand-name asset previously treated as indefinite-lived began being amortized over 15 years in 2022.
Cash, liquidity and debt
At March 31, cash and cash equivalents were $8.0 million, including $0.6 million of restricted escrow cash. Current assets were $29.6 million and current liabilities $13.1 million. The company reported $2.8 million outstanding on its revolving credit facility, with $2.2 million available, and $4.2 million of note payable, net of financing costs. The term loan bears interest at 2.42% at quarter-end and matures in 2026; the revolver matures in June 2025. Lifeway stated it complied with its debt covenants, including minimum working capital and fixed-charge coverage requirements.
Cash declined $1.2 million during the quarter, to $8.0 million, reflecting operating cash use of $0.6 million, investing cash use of $0.3 million, and $0.3 million of term-loan principal repayments. Management said cash, operating cash flow and available borrowing capacity were expected to support working capital, capital needs and growth initiatives, while noting that severe economic or credit-market disruption could adversely affect liquidity.
Outlook, risks and other notable matters
- No specific revenue, earnings or margin guidance was provided. Management expected continued pressure from milk prices and other input costs in 2022; pricing actions may lag cost increases or may not fully offset them.
- Management reported no significant COVID-related supply or labor disruption to date, but warned that future pandemic effects, inflation, supply-chain or transportation disruptions, and shifts in pandemic-era consumer demand could affect results.
- The 2021 comparative financial statements were restated for previously identified errors in accounting for deferred tax liabilities and goodwill related to a 2009 acquisition. Legal and professional expenses associated with the restatement increased Q1 2022 G&A.
- Management said disclosure controls were effective at March 31, 2022, but the previously disclosed material weakness in internal control over financial reporting remained under remediation, including work with a third-party provider on income-tax accounting. The filing warns that an unremediated deficiency could cause material misstatements.
- Two major customers represented approximately 21% of Q1 2022 sales. Ordinary-course legal matters were disclosed; management said current accruals were not material and expected no material adverse effect, while acknowledging an adverse outcome could be significant.
- The company settled its one unrecognized tax benefit during the quarter. The 2022 interim tax calculation used a discrete effective-rate method because changes in estimated annual income or loss could make the usual method unreliable.
Investor verification priorities
- Assess whether price increases and sales growth can offset elevated milk, freight, packaging and other input costs, and whether gross margin stabilizes.
- Review operating cash conversion, working-capital needs, capital spending and the remaining $2.2 million revolver availability.
- Track debt covenant compliance and scheduled term-loan repayments.
- Follow remediation of the financial-reporting material weakness and the accuracy of tax accounting in subsequent filings.
- Examine the restatement disclosures and evaluate customer concentration, legal contingencies and the potential normalization of post-pandemic demand.